Commonly reported side effects of ceritinib include: abdominal pain, diarrhea, hyperglycemia, increased serum alanine aminotransferase, nausea, and vomiting. Other side effects include: interstitial pulmonary disease, pneumonitis, and prolonged qt interval on ecg.  See below for a comprehensive list of adverse effects.
Applies to ceritinib: oral capsule
In addition to its needed effects, some unwanted effects may be caused by ceritinib. In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking ceritinib:
Some of the side effects that can occur with ceritinib may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to ceritinib: oral capsule
The most common side effect resulting in dose reductions or interruptions were increased ALT (29%), nausea (20%), increased AST (16%), diarrhea (16%), and vomiting (16%).  The most common side effects leading to discontinuation were pneumonia, interstitial lung disease/pneumonitis, and decreased appetite.[Ref]
Very common (10% or more): Diarrhea (86%), nausea (80%), vomiting (60%), abdominal pain (54%), constipation (29%), esophageal disorder (16%)Rare (less than 0.1%): Gastrointestinal hemorrhage[Ref]
Very Common (10% or more): Hemoglobin decreased (84%), phosphate decreased (36%)[Ref]
Very Common (10% or more): ALT increased (80%), AST increased (75%), bilirubin increased (15%)[Ref]
Very Common (10% or more): Creatinine increased (58%), phosphate decreased (36%)[Ref]
Very common (10% or more): Decreased appetite (34%), glucose increased (49%), lipase increased (28%)[Ref]
Very common (10% or more): Rash (16%)[Ref]
Common (1% to 10%): Interstitial lung disease/pneumonitisRare (0.01% than 0.1%): Respiratory failure, pneumothorax, pulmonary tuberculosis[Ref]
Very common (10% or more): Neuropathy (17%)[Ref]
Common (1% to 10%): Vision disorder[Ref]
Common (1% to 10%): Prolonged QT, bradycardiaRare (less than 0.1%): Cardiac tamponade[Ref]
Very common (10% or more): Fatigue (52%)Uncommon (0.1% to 1%): General physical health deteriorationRare (less than 0.1%): Sepsis[Ref]
1. "Product Information. Zykadia (ceritinib)." Novartis Pharmaceuticals, East Hanover, NJ. 
Not all side effects for ceritinib may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Abdominal or stomach pain or tenderness
blurred vision
burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
clay colored stools
dark urine
decreased appetite
dry mouth
fever
flushed, dry skin
fruit-like breath odor
headache
increased hunger
increased thirst
increased urination
loss of appetite
nausea and vomiting
skin rash or itching
sweating
swelling of the feet or lower legs
troubled breathing
unexplained weight loss
unsteadiness or awkwardness
unusual tiredness or weakness
weakness in the arms, hands, legs, or feet
yellow eyes or skin


Chest pain
chills
cough
fainting
general feeling of discomfort or illness
irregular heartbeat, recurrent
thickening of bronchial secretions


Blurred vision or other changes in vision
decreased appetite
diarrhea
difficulty having a bowel movement (stool)
heartburn
pain or discomfort in the chest, upper stomach, or throat
seeing flashes or sparks of light

